Lebrikizumab, MOMETASONE , Placebo for Lebrikizumab
J2T-MC-KGBU
Phase 3 small_molecule active
Quick answer
Lebrikizumab, MOMETASONE , Placebo for Lebrikizumab for Chronic Rhinosinusitis With Nasal Polyps (CRSwNP) is a Phase 3 program (small_molecule) at Eli Lilly Co. with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Eli Lilly Co.
- Indication
- Chronic Rhinosinusitis With Nasal Polyps (CRSwNP)
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active